F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
Official title: Evaluation of the F&P PAP Mask, US, 2026
Run by Fisher and Paykel Healthcare · NCT07826429 · Data updated 2026-11-12
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Fisher and Paykel Healthcare Industry-sponsored |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | September 28, 2026 |
| Main results expected | April 21, 2027 |
| Study ends | June 21, 2027 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07826429 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥22 years) who are current PAP/NIV users with at least 3 months of use and adequate nightly adherence, fluent in English, and able to consent.
✕Probably not a fit
Patients who do not meet adherence criteria or have conditions making PAP/NIV therapy inappropriate may not benefit from this mask evaluation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to validate performance, safety, usability, reliability, and acceptability of the F&P Licorice PAP mask in a home setting for adults with chronic respiratory conditions, including obstructive sleep apnea. Eligible participants are existing PAP/NIV users who meet usage and literacy criteria and are evaluated in a real-world environment. The study focuses on adherence, user experience, and basic safety outcomes to support potential device adoption. Recruitment is centralized at Clayton Sleep Institute in St. Louis, under Fisher and Paykel Healthcare as the lead sponsor. No collaborators are listed.
Why it matters
Potential benefit: If successful, patients may experience improved comfort and adherence with PAP/NIV therapy using the F&P mask, potentially enhancing treatment effectiveness.
How similar studies have gone: Prior studies of PAP masks suggest that comfort and usability improvements can improve adherence, though results vary by device and population, making this signal exploratory in nature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Are ≥22 years of age * Weigh ≥66 pounds * Have been prescribed PAP/NIV therapy by a physician * Are an existing PAP/NIV therapy mask user with ≥3 months of use prior to enrolment in the clinical investigation\* * Are compliant with PAP/NIV therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical investigation * Are fluent in spoken and written English * Possess the capacity to provide informed consent Exclusion Criteria: * Are intolerant to PAP/NIV therapy * Possess, or suffer from, anatomical or physiological conditions which make PAP/NIV therapy inappropriate * Are required to use PAP/NIV therapy for \>12 hours per day or for extensive periods, not including sleep or naps * Are trying to get pregnant, are pregnant, or think they may be pregnant * Have an IPAP pressure of \>30 cmH2O if on BPAP * Use a PAP/NIV therapy device for the delivery of medicines, except supplemental O2 * Use a PAP/NIV therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the clinical investigation site * Have a history of light-induced seizures (for optional anthropometric scan only)
Where it's running
-
Clayton Sleep Institute
St Louis, Missouri, United States Recruiting
Study contacts
- Study coordinator: Clinical Research Scientist
- Email: cpap.trial@fphcare.co.nz
- Phone: +6421436485
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep apnea biomarkers and CPAP use after diagnosis
This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.
-
Using the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
This real-world study tests whether the PLATO questionnaire can be feasibly used in dental sleep clinics for patients receiving oral appliance therapy for obstructive sleep apnea.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
-
OSA Screening in Diverse Populations
This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.
-
Wall Squat Exercise to Help Lower Blood Pressure in Adults with Hypertension and Sleep Apnea
This study tests whether doing an isometric wall squat can lower blood pressure in adults who have high blood pressure and sleep apnea treated with CPAP.
-
Biomarkers in Obstructive Sleep Apnea: Could Blood Tests Help Screen and Track OSA?
This study tests whether blood biomarkers can help screen for, diagnose, and monitor obstructive sleep apnea in adults, including an analysis of treatment response with PAP therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.